The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder

Table 2 The prevalence of metabolic syndrome components based on modified WHO criteria in NMOSD and control groups

Metabolic syndrome component	NMOSD N = 56	Control N = 100	Un-adjusted p-value
Hypertension (≥140/90 mmHg)	3 (5.4%)	2 (2.0%)	0.35^a
Dyslipidemia (triglycerides ≥150 mg/dl or HDL cholesterol < 40 mg/dl)	30 (53.6%)	52 (52.0%)	0.87
Hyperglycemia (Fasting glucose ≥110 mg/dl)	0 (0.0%)	4 (4.0%)	0.29^a
Hyperinsulinemia (forth Quartile)	27 (48.2%)	26 (26.0%)	0.005
waist girth ≥94 cm	11 (19.6%)	16 (16.0%)	0.56
IS_QUICKI	0.32 ± 0.04	0.35 ± 0.02	0.0001

ISSN: 1471-2377